The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus

The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus

BackgroundDiabetes mellitus (DM) is a frequent comorbidity in patients with cancer. This study aimed to evaluate the prognosis of advanced non-small cell lung cancer (NSCLC) patients with DM and to assess whether an optimal glycemic control improves overall survival (OS).MethodsA total of 1279 advan...

Full description

Bibliographic Details
Main Authors: Jie Qian, Weimin Wang, Lin Wang, Jun Lu, Lele Zhang, Bo Zhang, Shuyuan Wang, Wei Nie, Yanwei Zhang, Yuqing Lou, Baohui Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
diabetes
prognosis
glycemic control
glycated hemoglobin A1C (HbA1C)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.745150/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.745150/full

Similar Items